New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2014
10:00 EDTAGN, VOLVY, WOOF, VAL, UCTT, TREX, SANM, RLGY, INWK, HBAN, HAS, EGAS, FIVE, DLR, FANG, CYS, BMRC, AXL, ZIONOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Allergan (AGN) upgraded to Buy from Neutral at UBS... American Axle (AXL) upgraded to Neutral from Underweight at JPMorgan... Bank of Marin (BMRC) upgraded to Buy from Hold at Sandler O'Neill... CYS Investments (CYS) upgraded to Buy from Hold at Wunderlich... Diamondback Energy (FANG) upgraded to Buy from Neutral at Roth Capital... Digital Realty (DLR) upgraded to Buy from Hold at Deutsche Bank... Five Below (FIVE) upgraded to Outperform from Market Perform at Wells Fargo... Gas Natural (EGAS) upgraded to Buy from Hold at Wunderlich... Hasbro (HAS) upgraded to Overweight from Equal Weight at Barclays... Huntington Bancshares (HBAN) upgraded to Outperform at Keefe Bruyette... InnerWorkings (INWK) upgraded to Buy from Hold at Feltl... Realogy (RLGY) upgraded to Buy from Neutral at Citigroup... Sanmina (SANM) upgraded to Hold from Sell at Deutsche Bank... Trex Company (TREX) upgraded at Stifel... Ultra Clean (UCTT) upgraded to Buy from Neutral at Roth Capital... VCA Inc. (WOOF) upgraded at Stifel... Valspar (VAL) upgraded to Conviction Buy from Neutral at Goldman... Volvo (VOLVY) upgraded to Neutral from Sell at Goldman... Zions Bancorp (ZION) upgraded to Buy from Neutral at Compass Point.
News For AGN;AXL;BMRC;CYS;FANG;DLR;FIVE;EGAS;HAS;HBAN;INWK;RLGY;SANM;TREX;UCTT;VAL;WOOF;VOLVY;ZION From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
October 9, 2014
06:46 EDTAGNAllergan raises Q3 EPS to $1.76-$1.78 from $1.44-$1.47, consensus $1.48
Expects Q3 product net sales to increase in excess of 17% in dollars compared to product net sales from 3Q13.
October 8, 2014
16:29 EDTVALU.S. Chemicals sector initiated with an Overweight at RBC Capital
RBC Capital started the U.S. Chemicals sector with an Overweight rating citing the growth of shale gas. The firm lists ethylene stocks LyondellBasell (LYB), Westlake Chemical (WLK) and Dow Chemical (DOW) its top picks in the space. RBC views coatings stocks as good ways to play the pending recovery in construction, and has Outperform ratings on Sherwin-Williams (SHW) and PPG Industries (PPG). RBC put its only Underperform rating in the sector on Axiall (AXLL), citing the company's short ethylene position and leverage to single-family housing.
16:20 EDTVALValspar initiated with a Sector Perform at RBC Capital
Subscribe for More Information
16:10 EDTAGNAllergan initiated with a Buy at Deutsche Bank
Subscribe for More Information
08:42 EDTAGNSalix shares should be bought on weakness, says Sterne Agee
After Reuters yesterday afternoon reported that Actavis (ACT) plans to make a new merger approach to Allergan (AGN), Sterne Agee believes that Salix's standalone value is $162. The firm expects the shares to reach that level following approval of its Xifaxan IBS-D drug after the February 2015 PDUFA date.
07:19 EDTAGNCBI to hold a conference
Subscribe for More Information
06:23 EDTAGNActavis more inclined to pursue Allergan over Salix, says Citigroup
Subscribe for More Information
October 7, 2014
18:29 EDTAGNOn The Fly: After Hours Movers
Subscribe for More Information
18:05 EDTAGNValeant, Pershing Square plan to raise Allergan bid by $15 a share, WSJ says
Subscribe for More Information
17:52 EDTAGNAllergan up 2.8% after Dow Jones says Valeant planning to boost bid for company
17:49 EDTAGNValeant up 3.9% after Dow Jones says planning to boost Allergan bid
Subscribe for More Information
17:47 EDTAGNValeant, Pershing Square planning to boost Allergan bid by $15 a share, DJ says
Subscribe for More Information
15:21 EDTAGNAllergan warms to sale as Actavis plans new approach, Reuters says
Subscribe for More Information
15:01 EDTAGNAllergan up 1.5% following report on Actavis planned approach on merger
14:59 EDTAGNActavis plans new approach to Allergan, Reuters reports
Subscribe for More Information
14:46 EDTUCTTApple supplier GT Advanced recovers some of yesterday's losses
Subscribe for More Information
10:29 EDTUCTTGT Advanced lists Apple, Airgas, GrafTech, Ultra Clean among top 30 creditors
Subscribe for More Information
07:48 EDTAGNSalix reinstated with a Buy at Jefferies
Subscribe for More Information
07:12 EDTAGNAllergan requests Ackman be hindered from voting at meeting, Bloomberg says
In an effort to avoid an unsolicited $54B acquisition offer from Valeant Pharmaceuticals (VRX), Allergan (AGN) filed a request in a California court for a judge to hinder Bill Ackmanís Pershing Square from voting its 10% stake at the December shareholder meeting, according to Bloomberg, citing the filing. A hearing regarding Allergan's request is set to occur on October 28. Reference Link
05:31 EDTHASHasbro signs global licensing agreement with PEZ
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use